SEC Form 4 · accession 0001477932-26-003633
ASP Isotopes Inc. · ASPI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul Elliot Mann
Officer — Chairman and CEO · Director
Period of report
May 28, 2026
Accepted (ET)
Jun 3, 2026 · 9:45 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001921865
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 28, 2026 | A | 2,233,555 | — | A | 9,830,940 | D | |
| Common StockF3 | Jun 1, 2026 | S | 83,758 | $7.88 | D | 9,747,182 | D | |
| Common StockF4 | Jun 2, 2026 | S | 83,758 | $8.29 | D | 9,663,424 | D | |
| Common StockF5 | Jun 3, 2026 | S | 83,759 | $7.76 | D | 9,579,845 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This award of common stock was issued to the reporting person pursuant to his Employment Agreement dated October 4, 2021, as amended on December 20, 2022 and April 5, 2024, and shall vest (subject to compliance with applicable vesting conditions) in four equal installments over a one-year period beginning on March 1, 2026.
- F2Represents "sell to cover" sales effected pursuant to a Rule 10b5-1 trading plan adopted by the filing person on December 30, 2025 to cover tax withholding obligations in connection with the quarterly vesting of a restricted stock award.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.49 to $8.14, inclusive. The reporting person undertakes to provide ASP Isotopes Inc. (the "Company"), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.81 to $8.52, inclusive. The reporting person undertakes to provide the Company, any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.53 to $8.13, inclusive. The reporting person undertakes to provide the Company, any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.